A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2) ; volume:82 ; number:4 ; day:20 ; month:7 ; year:2018 ; pages:585-592 ; date:10.2018
Cancer chemotherapy and pharmacology ; 82, Heft 4 (20.7.2018), 585-592, 10.2018
- Urheber
-
Tanaka, Yusuke
- Beteiligte Personen und Organisationen
-
Ueda, Yutaka
Nakagawa, Satoshi
Matsuzaki, Shinya
Kobayashi, Eiji
Shiki, Yasuhiko
Nishio, Yukihiro
Takemura, Masahiko
Yamamoto, Toshiya
Sawada, Kenjiro
Tomimatsu, Takuji
Yoshino, Kiyoshi
Kimura, Tadashi
SpringerLink (Online service)
- DOI
-
10.1007/s00280-018-3648-y
- URN
-
urn:nbn:de:101:1-2018102813301058931215
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tanaka, Yusuke
- Ueda, Yutaka
- Nakagawa, Satoshi
- Matsuzaki, Shinya
- Kobayashi, Eiji
- Shiki, Yasuhiko
- Nishio, Yukihiro
- Takemura, Masahiko
- Yamamoto, Toshiya
- Sawada, Kenjiro
- Tomimatsu, Takuji
- Yoshino, Kiyoshi
- Kimura, Tadashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Primary Squamous Cell Carcinoma of Breast Responsive to Platinum and Taxane-Based Chemotherapy: A Rare Entity and Review Literature
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Platinum coordination complexes in cancer chemotherapy
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Primary Squamous Cell Carcinoma of Breast Responsive to Platinum and Taxane-Based Chemotherapy: A Rare Entity and Review Literature
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Platinum coordination complexes in cancer chemotherapy
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Primary Squamous Cell Carcinoma of Breast Responsive to Platinum and Taxane-Based Chemotherapy: A Rare Entity and Review Literature
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Platinum coordination complexes in cancer chemotherapy
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy